Select Page

Research involving a causal link between COVID-19 and diabetes has surfaced in a study published in The Lancet Diabetes & Endocrinology in March. Researchers gathered results showing people who suffered from COVID-19 were 40% more likely than controls to develop Type 2 diabetes.

Dr. Brian Fertig, M.D., founder and president of the Diabetes & Osteoporosis Center in Piscataway, New Jersey, told BioSpace that the increased risk of diabetes can be included to the list of long-term COVID side effects.

Fertig’s typical recommendation for management of type 2 diabetes involves a low dosage of pioglitazone, metformin and a Glucagon-like peptide-1 (GLP-1) agent. GLP-1 antagonists aid in weight loss, which improves insulin sensitivity and reduces blood glucose levels.

Read more here